|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61P 9/00 | |||
| A61K 31/00 | |||
| A61K 38/02 | |||
| C07K 16/40 |
| (11) | Number of the document | 2386316 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10183216.0 |
| Date of filing the European patent application | 2005-06-09 | |
| (97) | Date of publication of the European application | 2011-11-16 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-28 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 578847 P | 2004-06-10 | US |
| (72) |
Schwaeble, Hans-Wilhelm, GB
Stover, Cordula M., GB
Tedford, Clark E., US
Parent, James B., US
Fujita, Teizo, JP
|
| (73) |
UNIVERSITY OF LEICESTER,
University Road, Leicester, Leicestershire LE1 7RH,
GB
Omeros Corporation, 201 Elliott Avenue West, Seattle, WA 98119, US |
| (54) | Methods for treating conditions associated with MASP-2 dependent complement activation |
| Methods for treating conditions associated with MASP-2 dependent complement activation |